Flow cytometry: Principles and clinical applications in hematology

Clinical Chemistry

Volumn 46, Issue 8 II, 2000, Pages 1221-1229

  Brown, M ^a   Wittwer, C ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; DNA; HEMOGLOBIN F; OKT 3;

ARTICLE; CELL FUNCTION; CELL SURFACE; CLINICAL LABORATORY; DNA DETERMINATION; ERYTHROCYTE; FLOW CYTOMETRY; FLUORESCENCE ANALYSIS; HEMATOLOGY; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; INSTRUMENTATION; LEUKEMIA; LEUKOCYTE; LIGHT SCATTERING; LYMPHOMA; PARTICLE SIZE; THROMBOCYTE;

EID: 0033884049     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/46.8.1221     Document Type: Article

References (102)

1. Flow cytometry and clinical diagnosis
2. Practical flow cytometry
3. Flow cytometry: Its applications in hematology
4. Introduction to flow cytometry: Principles, fluorochromes, instrument set-up, calibration
5. The early fluidic and optical physics of cytometry
6. Principles of flow cytometry
7. DNA aneuploidy in adenomas of endocrine organs
8. DNA aneuploidy in follicular adenomas of the thyroid gland
9. DNA cytometry consensus conference
10. Clinical and biological significance of aneuploidy in human tumours
11. Consensus review of the clinical utility of DNA flow cytometry in neoplastic hematopathology
12. Improved DNA content histograms from formalin-fixed, paraffin-embedded liver tissue by proteinase K digestion
13. Prognostic importance of blast cell DNA content in childhood acute lymphoblastic leukemia
14. DNA flow cytometry in solid tumors: Practical aspects and clinical applications
15. Clinical aspects of alveolar rhabdomyosarcoma with translocation t(1;13)(p36;q14) and hypotetraploidy
16. Cytogenetics of cranial base tumors
17. Use of Rh immune globulin: ASCP practice parameter
18. Evaluation of methods for detection and quantitation of fetal cells and their effect on RhlgG usage
19. Detecting fetomaternal hemorrhage: A comparison of five methods [see comments]
20. Measurement of feto-maternal haemorrhage: A comparative study of three Kleihauer techniques and two flow cytometry methods
21. Detection of fetal red cells in fetomaternal hemorrhage using a fetal hemoglobin monoclonal antibody by flow cytometry
22. New method for quantitative determination of fetal hemoglobin-containing red blood cells by flow cytometry: Application to sickle-cell disease
23. Detection of hemoglobin variants in erythrocytes by flow cytometry
24. Flow cytometry in diagnosis and management of large fetomaternal haemorrhage
25. Strategies for rare-event detection: An approach for automated fetal cell detection in maternal blood
26. Fetal cell detection in maternal blood: A study in 236 samples using erythroblast morphology, DAB and HbF staining, and FISH analysis
27. Quantitation of fetal-maternal hemorrhage by flow cytometry. A simple and accurate method
28. Flow cytometric analysis of decay-accelerating factor (CD55) on neutrophils from aplastic anaemia patients
29. The use of monoclonal antibodies and flow cytometry in the diagnosis of paroxysmal nocturnal hemoglobinuria
30. Somatic mutations of the PIG-A gene found in Japanese patients with paroxysmal nocturnal hemoglobinuria
31. The PIG-A gene somatic mutation responsible for paroxysmal nocturnal hemoglobinuria
32. Erythrocytic disorders
33. Markedly high population of affected reticulocytes negative for decay-accelerating factor and CD59 in paroxysmal nocturnal hemoglobinuria
34. Immunophenotypic analysis of reticulocytes in paroxysmal nocturnal hemoglobinuria
35. Blood cell flow cytometry in paroxysmal nocturnal hemoglobinuria: A tool for measuring the extent of the PNH clone
36. Hematopoiesis
37. Flow cytometric reticulocyte quantification using thiazole orange provides clinically useful reticulocyte maturity index
38. Flow cytometric reticulocyte maturity index: A useful laboratory parameter of erythropoletic activity in anemia
39. Enumeration of reticulocytes using fluorescence-activated flow cytometry
40. Kinetics of erythrogenesis after bone marrow trans plantation
41. Utility of flow cytometric reticulocyte quantification as a predictor of engraftment in autologous bone marrow transplantation
42. Clinical analyzers. Advances in automated cell counting
43. Applications of flow cytofluorometry to red blood cell immunology
44. A flow cytometric method for phenotyping recipient red cells following transfusion
45. Flow cytometric analysis of residual white blood cell concentration and platelet activation antigens in double filtered platelet concentrates
46. Flow cytometric determination of residual leucocytes in filter-depleted blood products: An evaluation of Becton-Dickinson's Leuco-COUNT system
47. HIV viral load markers in clinical practice
48. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma
49. The immunophenotype of adult acute myeloid leukemia: High frequency of lymphoid antigen expression and comparison of immunophenotype, French-American-British classification, and karyotypic abnormalities
50. Membrane antigen analysis in the diagnosis of lymphoid leukemias and lymphomas. Differential diagnosis, prognosis as related to immunophenotype, and recommendations for testing
51. Clinically useful information provided by the flow cytometric immunophenotyping of hematological malignancies: Current status and future directions
52. Comprehensive review of adult acute myelogenous leukemia: Cytomorphological, enzyme cytochemical, flow cytometric immunophenotypic, and cytogenetic findings
53. Report on the first Latin American Consensus Conference for Flow Cytometric Immunophenotyping of Leukemia
54. Clinical utility of flow cytometry in the chronic lymphoid leukemias
55. U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: Medical indications
56. U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: Data reporting
57. U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: Data analysis and interpretation
58. U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: Selection of antibody combinations
59. U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: Standardization and validation of laboratory procedures
60. Recent advances in flow cytometry: Application to the diagnosis of hematologic malignancy
61. Unique immunophenotype of acute promyelocytic leukaemia as defined by CD9 and CD68 antibodies
62. The unique aspects of acute promyelocytic leukemia
63. Flow cytometric determination of the multidrug-resistant phenotype in acute leukemia
64. Acute lymphoblastic leukemia
65. Impact of immunophenotyping on management of acute leukemias
66. Flow cytometric immunophenotyping of non-Hodgkin's lymphomas and related disorders
67. Gamma/delta T-cell hepatosplenic lymphoma: Review of the literature, diagnosis by flow cytometry and concomitant autoimmune hemolytic anemia
68. Transient T cell receptor beta-chain variable region-specific expansions of CD4+ and CD8+ T cells during the early phase of pediatric human immunodeficiency virus infection: Characterization of expanded cell populations by T cell receptor phenotyping
69. Elevation of gamma delta T lymphocytes in peripheral blood and livers of patients with primary sclerosing cholangitis and other autoimmune liver diseases
70. Flow cytometry in cytopathology. Overview and perspectives
71. Assessment of minimal residual disease in patients with acute leukemia
72. The immunologic detection of minimal residual disease in acute leukemia
73. Detection of minimal residual disease (MRD) after bone marrow transplantation (BMT) by multi-parameter flow cytometry (MPFC)
74. Acute lymphoblastic leukemia (ALL): Detection of minimal residual disease (MRD) at flow cytometry
75. Detection of minimal residual disease in acute myeloid leukaemia: Methodologies, clinical and biological significance
76. Autoantibodies to leukocyte alphaMbeta2 integrin glycoproteins in HIV infection
77. The use of flow cytometry to measure neutrophil function
78. The CD11/CD18 leukocyte glycoprotein deficiency
79. Leukocyte CD11/CD18 integrins: Biological and clinical relevance
80. Detection of platelet antigen for antiplatelet antibodies in idiopathic thrombocytopenic purpura by flow cytometry, antigen-capture ELISA, and immunoblotting: A comparative study
81. Detection of platelet alloantibodies by flow cytometry. Characterization and clinical significance
82. Detection of platelet antibodies in chronic idiopathic thrombocytopenic purpura (ITP). A comparative study using flow cytometry, a whole platelet ELISA, and an antigen capture ELISA
83. Detection of platelet-associated antibodies by flow cytometry in hematological autoimmune disorders
84. Frequency and causes of refractoriness in multiply transfused patients
85. Comparative study of three methods to detect free plasma antiplatelet antibodies
86. Determination of the percentage of thiazole orange (TO)-positive, 'reticulated' platelets using autologous erythrocyte TO fluorescence as an internal standaro
87. Flow cytometric analysis of thiazole orange uptake by platelets: A diagnostic aid in the evaluation of thrombocytopenic disorders
88. Reticulated platelets in the evaluation of thrombopoietic disorders
89. Rapid heterozygote detection in Glanzmann's thrombasthenia
90. Analysis of platelet aggregation disorders based on flow cytometric analysis of membrane glycoprotein IIb-IIIa with conformation-specific monoclonal antibodies
91. Flow cytometric analysis of platelet surface glycoproteins in the diagnosis of Bernard-Soulier syndrome
92. Bernard-Soulier syndrome: A flow cytometric analysis of membrane GP-Ib expression
93. Partial expression of GP Ib measured by flow cytometry in two patients with Bernard-Soulier syndrome
94. Bernard-Soulier syndrome: Quantitative characterization of megakaryocytes and platelets by flow cytometric and platelet kinetic measurements
95. Flow cytometry: A clinical test of platelet function
96. Laboratory markers of platelet activation and their clinical significance
97. Flow cytometric detection of circulating activated platelets in primary antiphospholipid syndrome. Correlation with thrombocytopenia and anticardiolipin antibodies
98. The quantitative flow cytometric plasma OKT3 assay. Its potential application in cardiac transplantation
99. Multiplexed analysis of human cytokines by use of the FlowMetrix system
100. A rapid, sensitive, multiplexed assay for detection of viral nucleic acids using the FlowMetrix system
101. Multiplexed quantification of human IgG, IgA, and IgM with the FlowMetrix system
102. Advanced multiplexed analysis with the FlowMetrix system